{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:55Z","timestamp":1761919195224,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.nic.2008.06.009","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T03:13:12Z","timestamp":1226373192000},"page":"577-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immunologic Mechanisms of Multiple Sclerosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Elliot M.","family":"Frohman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Eagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Monson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Stuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nic.2008.06.009_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Medical progress: multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0025-7125(03)00008-7","article-title":"Multiple sclerosis","volume":"87","author":"Frohman","year":"2003","journal-title":"Med Clin N Am"},{"issue":"11","key":"10.1016\/j.nic.2008.06.009_bib3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/01.WNL.0000096175.39831.21","article-title":"Effect of relapses on development of residual deficit in multiple sclerosis","volume":"61","author":"Lublin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2008.06.009_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0404.1979.tb02968.x","article-title":"Does the history of multiple sclerosis go back as far as the 14th century?","volume":"60","author":"Maeder","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nic.2008.06.009_bib5","first-page":"554","article-title":"Histologie de la sclerose en plaques","volume":"41","author":"Charcot","year":"1868","journal-title":"Gaz Hop Civils Milit (Paris)"},{"key":"10.1016\/j.nic.2008.06.009_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in multiple sclerosis","volume":"122","author":"Schumacher","year":"1965","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nic.2008.06.009_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.nic.2008.06.009_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.WNL.0000082654.99838.EF","article-title":"The utility of MRI in suspected MS. The Therapeutics and Technology Assessment Committee of the American Academy of Neurology","volume":"61","author":"Frohman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2008.06.009_bib11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2008.06.009_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J\u00a0Med"},{"issue":"9585","key":"10.1016\/j.nic.2008.06.009_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2008.06.009_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF01878008","article-title":"Histologische detail zu der grauen degeneration von gehirn and ruckenmark","volume":"26","author":"Rindfleisch","year":"1863","journal-title":"Virchow Arch Path Anat Physiol"},{"key":"10.1016\/j.nic.2008.06.009_bib15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis: the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI1528","article-title":"Decreased dependence of myelin basic protein-reactive T cells on CD28 mediated costimulation in multiple sclerosis patients: a marker of activated memory T cells","volume":"101","author":"Lovett-Racke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2008.06.009_bib17","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.160.3.1532","article-title":"Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation","volume":"160","author":"Scholz","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(03)00221-2","article-title":"Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression","volume":"141","author":"Moldavan","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nic.2008.06.009_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.49.2.351","article-title":"Treatment of multiple sclerosis with monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MRI-monitored phase II trial","volume":"49","author":"van Oosten","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2008.06.009_bib20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1172\/JCI119396","article-title":"Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating na\u00efve T cells but does not affect IFN gamma secreting TH1 cells in humans","volume":"99","author":"Rep","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2008.06.009_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nic.2008.06.009_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1126\/science.1142331","article-title":"Emerging challenges in regulatory T cell function and biology","volume":"317","author":"Sakaguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.nic.2008.06.009_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nic.2008.06.009_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1750-3639.1996.tb00854.x","article-title":"Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis","volume":"6","author":"Lucchinetti","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nic.2008.06.009_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2008-1040885","article-title":"Multiple sclerosis: lessons from neuropathology","volume":"18","author":"Lucchinetti","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.nic.2008.06.009_bib28","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","article-title":"High prevalence of autoreactive neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay","volume":"103","author":"Crawford","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.nic.2008.06.009_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1172\/JCI200214380","article-title":"Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis","volume":"109","author":"Karandikar","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2008.06.009_bib30","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nic.2008.06.009_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI101335","article-title":"An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins","volume":"21","author":"Kabat","year":"1942","journal-title":"J\u00a0Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.nic.2008.06.009_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2007.08.030","article-title":"Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis","volume":"266","author":"Villar","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nic.2008.06.009_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm0502-509","article-title":"Autoimmunity due to molecular mimicry as a cause of neurological disease","volume":"8","author":"Levin","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2008.06.009_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0952-7915(03)00008-6","article-title":"Antigen receptor selection by editing or downregulation of V(D)J recombination","volume":"15","author":"Nemazee","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib35","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.171.5.2725","article-title":"Single cell repertoire analysis demonstrates clonal expansion is prominent feature of the B cell response in multiple sclerosis spinal fluid","volume":"171","author":"Owens","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nic.2008.06.009_bib38","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.166.12.7144","article-title":"The frequency of high avidity T cells determines the hierarchy of determinant spreading","volume":"166","author":"Tian","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80533-6","article-title":"Cytokines induce the development of functionally heterogeneous T helper cell subsets","volume":"8","author":"O'Garra","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.nic.2008.06.009_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.94.2.599","article-title":"Increased IL-12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand","volume":"94","author":"Balashov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nic.2008.06.009_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib42","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI3125","article-title":"Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy","volume":"102","author":"Comabella","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2008.06.009_bib44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells","volume":"12","author":"Seder","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.nic.2008.06.009_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(87)92863-7","article-title":"Exacerbations of multiple sclerosis in patients treated with gamma interferon","volume":"1","author":"Panitch","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.nic.2008.06.009_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","article-title":"Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA","volume":"265","author":"Steimle","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nic.2008.06.009_bib48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nic.2008.06.009_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nic.2008.06.009_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nic.2008.06.009_bib52","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/WNL.40.9.1399","article-title":"Anoxic injury of CNS white matter: protective effect of ketamine","volume":"40","author":"Ransom","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2008.06.009_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1523\/JNEUROSCI.12-02-00430.1992","article-title":"Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na_-Ca2_ exchanger","volume":"12","author":"Stys","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.nic.2008.06.009_bib54","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1073\/pnas.0402765101","article-title":"Molecular changes in neurons in MS: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na_\/C2_ exchanger in the human CNS","volume":"101","author":"Craner","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nic.2008.06.009_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.96","article-title":"Electrically active axons degenerate when exposed to nitric oxide","volume":"49","author":"Smith","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10443","article-title":"Blockers of sodium and calcium entry protect axons from nitric oxide mediated degeneration","volume":"53","author":"Kapoor","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.10397","article-title":"NO and the axonal death cascade","volume":"53","author":"Waxman","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2008.06.009_bib58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-6273(02)00770-5","article-title":"Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth","volume":"35","author":"Domeniconi","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nic.2008.06.009_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0198-8859(96)00064-X","article-title":"Tumor necrosis factor microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex, and TNF secretion","volume":"50","author":"Garcia-Merino","year":"1996","journal-title":"Hum Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib60","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the pro-inflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nic.2008.06.009_bib61","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.nic.2008.06.009_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nri1108","article-title":"Transcriptional analysis of targets in multiple sclerosis","volume":"3","author":"Steinman","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nic.2008.06.009_bib63","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.10606","article-title":"Elevated osteopontin levels are associated with disease activity in relapsing-remitting MS patients","volume":"53","author":"Vogt","year":"2003","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.nic.2008.06.009_bib64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"International Multiple Sclerosis Genetics Consortium","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514908000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514908000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:03:29Z","timestamp":1760943809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514908000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1052514908000610"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2008.06.009","relation":{},"ISSN":["1052-5149"],"issn-type":[{"type":"print","value":"1052-5149"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic Mechanisms of Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2008.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}